UK markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
33.93+1.91 (+5.97%)
At close: 04:00PM EST
33.62 -0.31 (-0.91%)
After hours: 07:57PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/09/2022
30/09/2021
30/09/2020
30/09/2019
Total revenue
243,231
243,231
138,287
87,992
168,796
Operating expenses
Research development
297,307
297,307
206,342
128,875
81,049
Selling general and administrative
124,431
124,431
80,981
52,276
26,556
Total operating expenses
421,738
421,738
287,323
181,151
107,605
Operating income or loss
-178,507
-178,507
-149,036
-93,159
61,191
Total other income/expenses net
5,798
5,798
2,070
-582.524
-
Income before tax
-172,709
-172,709
-140,846
-84,551
68,148
Income tax expense
-
-
2
2.4
173.553
Income from continuing operations
-172,709
-172,709
-140,848
-84,553
67,975
Net income
-172,709
-172,709
-140,848
-84,553
67,975
Net income available to common shareholders
-172,709
-172,709
-140,848
-84,553
67,975
Basic EPS
-
-
-1.36
-0.84
0.72
Diluted EPS
-
-
-1.36
-0.84
0.69
Basic average shares
-
-
103,745
100,722
93,859
Diluted average shares
-
-
103,745
100,722
98,608
EBITDA
-
-178,507
-140,769
-87,217
65,630